“A desire by pathologists to identify myocarditis might have played a role,” wrote co-authors Marc Halushka, MD, PhD, a professor of pathology at Johns Hopkins University School of Medicine in Baltimore, and Richard Vander Heide, MD, PhD, director of pathology research at LSU Health New Orleans School of Medicine. “The first COVID-19 autopsy…
Researchers explored data from nearly 2,500 AFib ablation patients, sharing their research in JAMA Cardiology.
James Januzzi Jr., MD, said the treatment’s overall impact was neutral, but he and his team saw “a very clear and encouraging signal.”
The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.
Svensson, a prominent voice in cardiothoracic surgery, said he has seen a rise in enthusiasm ahead of this year’s meeting.
The Society for Cardiovascular Angiography & Interventions and Society of Thoracic Surgeons have both shared statements in support of the ban, which is already being…
Pharmacists interact with patients on a regular basis and are seen as a trusted source of health information. Can they help cardiologists improve care for…
TAVR was initially associated with greater benefits than surgery, but that difference faded by the end of the first year.
Munster, Indiana, is a thriving suburb 30 miles south of the heart of Chicago. It’s a place where the locals like to stay local, especially…
